Muutke küpsiste eelistusi

E-raamat: Vitreoretinal Disorders

Edited by
Teised raamatud teemal:
  • Formaat - EPUB+DRM
  • Hind: 98,18 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book discusses the newest trends, concepts, and advancements in the management of vitreo-retinal conditions. The field of retina is rapidly changing, with new advances ranging from stem cell therapy, gene therapy and editing, new drug targets, novel delivery systems, and innovative technologies in advanced ocular imaging and surgical techniques. The goal is to provide a way to update practitioners and trainees on how the field of retina is changing. Areas of focus include new technologies, particularly in ocular imaging and vitreo-retinal surgery, major new clinical trials, particularly those that are shifting practice patterns or addressing novel therapies, and novel research that is altering the classification and diagnosis of retinal conditions, as well as management strategies and prognostic predictors for vitreo-retinal diseases.

This volume is essential reading for generalist and specialist ophthalmologists and useful for residents and fellows training in various subspecialties.

Arvustused

The book covers the majority of the more frequently seen vitreoretinal diseases and describes the findings on current imaging modalities. It covers advanced imaging techniques, giving insight into the pathophysiology of the diseases. This is a good, handy resource for physicians, residents, and medical students. It is small and easy to carry, which might be helpful for a many of these potential readers. It provides the latest knowledge and will be a resource for years to come. (Diana V. Do, Doody's Book Reviews, October, 2018)

Ocular Imaging.- Age-Related Macular Degeneration.- Retina in Diabetic
Eye Diseases.- Retinal and Choroidal Vascular Diseases.- Inherited Retinal
Diseases and Gene Therapy.- Pediatric Retina.- Retinal Detachment
Surgery.- Macular Surgery.- 1.Surgical Instrumentation and Devices.

 


 


 




 





 


 




 . 
Glenn Yiu is a clinician-scientist and Assistant Professor of Ophthalmology at UC Davis, where he combines clinical practice in vitreo-retinal surgery with laboratory research studying the pathogenesis and treatment of age-related macular degeneration (AMD) and other retinal diseases. He obtained his medical and graduate degrees from Harvard Medical School, then underwent residency training at the Massachusetts Eye & Ear Infirmary, followed by fellowship in vitreo-retinal surgery at Duke. Dr. Yiu has published numerous peer-reviewed scientific papers and book chapters, and has given lectures nationally and internationally. He is a reviewer for several ophthalmology journals, and is a course lecturer at the American Academy of Ophthalmology. He has also been the recipient of numerous prestigious awards including the Ronald G. Michels Foundation Fellowship Award, the Heed Ophthalmic Foundation Fellowship Award, the Retina Society Fellowship Research Award, and theMacula Society Evangelos S. Gragoudas Award. In 2016, he was named as one of 21 "Emerging Vision Scientists" by the National Alliance for Eye and Vision Research for his cutting edge research.